6HG4 image
Deposition Date 2018-08-22
Release Date 2020-03-18
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6HG4
Keywords:
Title:
Crystal Structure of the human IL-17RC ECD in complex with human IL-17F
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.32 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 3 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Interleukin-17F
Gene (Uniprot):IL17F
Chain IDs:A
Chain Length:139
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Interleukin-17 receptor C
Gene (Uniprot):IL17RC
Mutations:N186Q, N226Q, N253Q, N263Q, N349Q, N372Q, N406Q
Chain IDs:B
Chain Length:451
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.
Immunity 52 499 512.e5 (2020)
PMID: 32187518 DOI: 10.1016/j.immuni.2020.02.004

Abstact

Interleukin-17A (IL-17A), IL-17F, and IL-17A/F heterodimers are key cytokines of the innate and adaptive immune response. Dysregulation of the IL-17 pathway contributes to immune pathology, and it is therefore important to elucidate the molecular mechanisms that govern IL-17 recognition and signaling. The receptor IL-17RC is thought to act in concert with IL-17RA to transduce IL-17A-, IL-17F-, and IL-17A/F-mediated signals. We report the crystal structure of the extracellular domain of human IL-17RC in complex with IL-17F. In contrast to the expected model, we found that IL-17RC formed a symmetrical 2:1 complex with IL-17F, thus competing with IL-17RA for cytokine binding. Using biophysical techniques, we showed that IL-17A and IL-17A/F also form 2:1 complexes with IL-17RC, suggesting the possibility of IL-17RA-independent IL-17 signaling pathways. The crystal structure of the IL-17RC:IL-17F complex provides a structural basis for IL-17F signaling through IL-17RC, with potential therapeutic applications for respiratory allergy and inflammatory bowel diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures